BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24021581)

  • 1. Selective inhibition of heme oxygenase-2 activity by analogs of 1-(4-chlorobenzyl)-2-(pyrrolidin-1-ylmethyl)-1H-benzimidazole (clemizole): Exploration of the effects of substituents at the N-1 position.
    Vlahakis JZ; Vukomanovic D; Nakatsu K; Szarek WA
    Bioorg Med Chem; 2013 Nov; 21(21):6788-95. PubMed ID: 24021581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-Activity Relationships of 1,2-Disubstituted Benzimidazoles: Selective Inhibition of Heme Oxygenase-2 Activity.
    Kong X; Vukomanovic D; Nakatsu K; Szarek WA
    ChemMedChem; 2015 Aug; 10(8):1435-41. PubMed ID: 26083133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imidazole-dioxolane compounds as isozyme-selective heme oxygenase inhibitors.
    Vlahakis JZ; Kinobe RT; Bowers RJ; Brien JF; Nakatsu K; Szarek WA
    J Med Chem; 2006 Jul; 49(14):4437-41. PubMed ID: 16821802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of azalanstat analogues as heme oxygenase inhibitors.
    Vlahakis JZ; Kinobe RT; Bowers RJ; Brien JF; Nakatsu K; Szarek WA
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1457-61. PubMed ID: 15713406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heme oxygenase inhibition by 1-aryl-2-(1h-imidazol-1-yl/1h-1,2,4-triazol-1-yl)ethanones and their derivatives.
    Roman G; Vlahakis JZ; Vukomanovic D; Nakatsu K; Szarek WA
    ChemMedChem; 2010 Sep; 5(9):1541-55. PubMed ID: 20652928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heme Oxygenase-2 (HO-2) as a therapeutic target: Activators and inhibitors.
    Intagliata S; Salerno L; Ciaffaglione V; Leonardi C; Fallica AN; Carota G; Amata E; Marrazzo A; Pittalà V; Romeo G
    Eur J Med Chem; 2019 Dec; 183():111703. PubMed ID: 31550661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heme oxygenase inhibition by 2-oxy-substituted 1-(1H-imidazol-1-yl)-4-phenylbutanes: effect of halogen substitution in the phenyl ring.
    Roman G; Riley JG; Vlahakis JZ; Kinobe RT; Brien JF; Nakatsu K; Szarek WA
    Bioorg Med Chem; 2007 May; 15(9):3225-34. PubMed ID: 17339115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential inhibition of rat and mouse microsome heme oxygenase by derivatives of imidazole and benzimidazole.
    Hum M; McLaughlin BE; Kong X; Vlahakis JZ; Vukomanovic D; Szarek WA; Nakatsu K
    Can J Physiol Pharmacol; 2017 Dec; 95(12):1454-1461. PubMed ID: 28793202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel imidazole derivatives as heme oxygenase-1 (HO-1) and heme oxygenase-2 (HO-2) inhibitors and their cytotoxic activity in human-derived cancer cell lines.
    Salerno L; Pittalà V; Romeo G; Modica MN; Marrazzo A; Siracusa MA; Sorrenti V; Di Giacomo C; Vanella L; Parayath NN; Greish K
    Eur J Med Chem; 2015; 96():162-72. PubMed ID: 25874340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of the heme oxygenase - carbon monoxide system: on the doorstep of the clinic?
    Kinobe RT; Dercho RA; Nakatsu K
    Can J Physiol Pharmacol; 2008 Sep; 86(9):577-99. PubMed ID: 18758507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of novel aryloxyalkyl derivatives of imidazole and 1,2,4-triazole as heme oxygenase-1 (HO-1) inhibitors and their antitumor properties.
    Salerno L; Pittalà V; Romeo G; Modica MN; Siracusa MA; Di Giacomo C; Acquaviva R; Barbagallo I; Tibullo D; Sorrenti V
    Bioorg Med Chem; 2013 Sep; 21(17):5145-53. PubMed ID: 23867390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of imidazole-dioxolane compounds as selective heme oxygenase inhibitors: effect of substituents at the 4-position of the dioxolane ring.
    Vlahakis JZ; Hum M; Rahman MN; Jia Z; Nakatsu K; Szarek WA
    Bioorg Med Chem; 2009 Mar; 17(6):2461-75. PubMed ID: 19268600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heme oxygenase inhibition by α-(1H-imidazol-1-yl)-ω-phenylalkanes: effect of introduction of heteroatoms in the alkyl linker.
    Vlahakis JZ; Lazar C; Roman G; Vukomanovic D; Nakatsu K; Szarek WA
    ChemMedChem; 2012 May; 7(5):897-902. PubMed ID: 22431362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a potent heme oxygenase-2 (HO-2) inhibitor by targeting the secondary hydrophobic pocket of the HO-2 western region.
    Floresta G; Fallica AN; Romeo G; Sorrenti V; Salerno L; Rescifina A; Pittalà V
    Bioorg Chem; 2020 Nov; 104():104310. PubMed ID: 33010625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of Novel Acetamide-Based Heme Oxygenase-1 Inhibitors with Potent
    Fallica AN; Sorrenti V; D'Amico AG; Salerno L; Romeo G; Intagliata S; Consoli V; Floresta G; Rescifina A; D'Agata V; Vanella L; Pittalà V
    J Med Chem; 2021 Sep; 64(18):13373-13393. PubMed ID: 34472337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro inhibition of heme oxygenase isoenzymes by metalloporphyrins.
    Wong RJ; Vreman HJ; Schulz S; Kalish FS; Pierce NW; Stevenson DK
    J Perinatol; 2011 Apr; 31 Suppl 1():S35-41. PubMed ID: 21448202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Modulation by Inhibitors of the HO System.
    Fernández-Fierro A; Funes SC; Rios M; Covián C; González J; Kalergis AM
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in the development of selective heme oxygenase-1 inhibitors and their potential therapeutic application.
    Salerno L; Floresta G; Ciaffaglione V; Gentile D; Margani F; Turnaturi R; Rescifina A; Pittalà V
    Eur J Med Chem; 2019 Apr; 167():439-453. PubMed ID: 30784878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural Insights into Azole-based Inhibitors of Heme Oxygenase-1: Development of Selective Compounds for Therapeutic Applications.
    Rahman MN; Vukomanovic D; Vlahakis JZ; Szarek WA; Nakatsu K; Jia Z
    Curr Med Chem; 2018; 25(42):5803-5821. PubMed ID: 30674243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heme oxygenase inhibition by 2-oxy-substituted 1-azolyl-4-phenylbutanes: effect of variation of the azole moiety. X-ray crystal structure of human heme oxygenase-1 in complex with 4-phenyl-1-(1H-1,2,4-triazol-1-yl)-2-butanone.
    Roman G; Rahman MN; Vukomanovic D; Jia Z; Nakatsu K; Szarek WA
    Chem Biol Drug Des; 2010 Jan; 75(1):68-90. PubMed ID: 19954435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.